Key result
Implantable cardiac electronic devices offer a potential strategy for identifying asymptomatic atrial fibrillation to initiate anticoagulant therapy and prevent stroke.
Discusses the potential of implantable cardiac electronic devices for identifying asymptomatic atrial fibrillation to prevent stroke.
Stroke that is related to atrial fibrillation is particularly debilitating and potentially lethal because of the size of the embolism that is caused by a left atrial thrombus. Therefore, the identification of asymptomatic atrial fibrillation and the subsequent initiation of anticoagulant therapy could translate into better outcomes for affected patients. Screening for paroxysmal atrial fibrillation has been impractical because of the transient and unpredictable nature of this condition and the fact that monitoring devices may not detect the atrial electrical activity that is needed for a definitive diagnosis. With the advent of implantable cardiac electronic devices that constantly monitor heart . . .
No takes yet. Share an insight, caveat, or question.
Stone et al. (2023) conducted an editorial in Atrial fibrillation and stroke. Implantable cardiac electronic devices was evaluated. Implantable cardiac electronic devices offer a potential strategy for identifying asymptomatic atrial fibrillation to initiate anticoagulant therapy and prevent stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: